Recovery of Varicella-Zoster Virus–Specific T Cell Immunity after T Cell–Depleted Allogeneic Transplantation Requires Symptomatic Virus Reactivation
✍ Scribed by Eva Distler; Elke Schnürer; Eva Wagner; Charis von Auer; Bodo Plachter; Daniela Wehler; Christoph Huber; Karin Kolbe; Ralf Georg Meyer; Wolfgang Herr
- Book ID
- 116280445
- Publisher
- Elsevier Science
- Year
- 2008
- Tongue
- English
- Weight
- 296 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1083-8791
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Recipients of allogeneic bone marrow transplantation are pancytopenic for several weeks and immunosuppressed for many months as a result of myeloablative therapy required to eliminate the basic disease and to prevent allograft rejection. After bone marrow transplantation, these patients remain profo
We investigated the adoptive transfer of immunity to herpes simplex virus (HSV) in 61 recipients of T-cell-depleted marrow allografts. Up to 3 months after bone marrow transplantation (BMT), high titres of HSV antibody (Ab) are passively acquired from blood products. This antibody has a half-life of
Hepatitis C virus (HCV)-related liver failure is the leading indication for liver transplantation worldwide. After transplantation, virological recurrence is the rule, but the spectrum of histological injury is wide, ranging from the development of allograft cirrhosis within a few years to minimal h